Bosentan prevents hypoxia-reoxygenation-induced pulmonary hypertension and improves pulmonary function

Annals of Thoracic Surgery

Volumn 68, Issue 5, 1999, Pages 1714-1721

  Pearl, Jeffrey M ^a   Wellmann, Scott A ^a   McNamara, Jerri L ^a   Lombardi, John P ^a   Wagner, Connie J ^a   Raake, Jenni L ^a   Nelson, David P ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOSENTAN; ENDOTHELIN 1; LIPID PEROXIDASE; MYELOPEROXIDASE; NITRITE;

AIRWAY RESISTANCE; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; HYPOXIA; IMMUNOASSAY; LUNG FUNCTION; LUNG VASCULAR RESISTANCE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SWINE;

EID: 0032758975     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(99)00988-1     Document Type: Conference Paper

References (40)

1. Pearl J.M., Wellmann S.A., Raake J.L., et al. Acute hypoxia and reoxygenation impairs exhaled nitric oxide release-suggesting bronchial epithelial injury. Circulation. 98:(Suppl 1):1998;63.
2. Snapper J.R., Thabes J.S., Lefferts P.L., Lu W. Role of endothelin in endotoxin-induced sustained pulmonary hypertension in sheep. Am J Respir Crit Care Med. 157:1998;81-88.
3. Cao W.B., Zeng Z.P., Zhu Y.J., Luo W.C., Cai B.Q. Inhibition of nitric oxide synthesis increases the secretion of endothelin-1 in vivo and in cultured endothelial cells. Chin Med J. 107:1994;822-826.
4. Shaul P.W., Wells L.B., Horning K.M. Acute and prolonged hypoxia attenuate endothelial nitric oxide production in rat pulmonary arteries by different mechanisms. J Cardiovasc Pharmacol. 22:1993;819-827.
5. McQuillan L.P., Leung G.K., Marsden S.K., Kostyk S.K., Kourembanas S. Hypoxia inhibits expression of eNOS via transcriptional and post-transcriptional mechanisms. Am J Physiol. 267:1994;H1921-H1927.
6. Nelin L.D., Thomas C.J., Dawson C.A. Effect of hypoxia on nitric oxide production in neonatal pig lung. Am J Physiol. 271:1996;H8-H14.
7. Hickey M.J., Sharkey K.A., Sihota E.G., et al. Inducible nitric oxide synthase-deficient mice have enhanced leukocyte-endothelium interactions in endotoxemia. FASEB J. 11:1997;955-964.
8. Helset E., Ytrehus K., Tveita T., Kjaeve J., Jorgensen L. Endothelin-1 causes accumulation of leukocytes in the pulmonary circulation. Circ Shock. 44:1994;201-209.
9. Boros M., Massberg S., Baranyi L., Okada H., Messmer K. Endothelin-1 induces leukocyte adhesion in submucosal venules of the rat small intestine. Gastroenterology. 114:1998;103-114.
10. Ishida K., Takeshige K., Minakami S. Endothelin-1 enhances superoxide generation of human neutrophils stimulated by the chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine. Biochem Biophys Res Commun. 173:1990;496-500.
11. Ihnken K., Morita K., Buckberg G.D., et al. Studies of hypoxemic/reoxygenation injury without aortic clamping. II. Evidence for reoxygenation damage . J Thorac Cardiovasc Surg. 110:1995;1171-1181.
12. Langregr J.M., Murase N., Markus P.M. Nitric oxide production in host-versus-graft and graft-versus-host reactions in the rat. J Clin Invest. 90:1992;679-683.
13. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 95:1979;351-358.
14. Tonz M., Mihaljevic T., von Segesser L.K., et al. Postoperative hemodynamics depend on cardiopulmonary bypass temperature the potential role of endothelin-1 . Eur J Cardiothorac Surg. 11:1997;157-161.
15. Kirshbom P.M., Tsui S.S., Dibernardo L.R., et al. Blockade of endothelin-converting enzyme reduces pulmonary hypertension after cardiopulmonary bypass and circulatory arrest. Surgery. 118:1995;440-444.
16. Hickey M.J., Sharkey K.A., Sihota E.G., et al. Inducible nitric oxide synthase-deficient mice have enhanced leukocyte-endothelium interactions in endotoxemia. FASEB J. 11:1997;955-964.
17. Kupatt C., Weber C., Wolf D.A., et al. Nitric oxide attenuates reoxygenation-induced ICAM-1 expression in coronary microvascular endothelium role of NFκB . J Mol Cell Cardiol. 29:1997;2599-2609.
18. Brunner F., Leonhard B., Kukovetz W.R., Mayer B. Role of endothelin, nitric oxide and L-arginine in ischemia/reperfusion injury of rat heart. Cardiovasc Res. 36:1997;60-66.
19. Redmond E.M., Cahill P.A., Hodges R., et al. Regulation of endothelin receptors by nitric oxide in cultured rat vascular smooth muscle cells. J Cell Physiol. 166:1996;469-479.
20. Holm P., Liska J., Clozel M., Franco-Cereceda A. The endothelin antagonist Bosentan hemodynamic effects during normoxia and hypoxic pulmonary hypertension in pigs . J Thorac Cardiovasc Surg. 112:1996;890-897.
21. Shirakami G., Nakao K., Saito Y., et al. Acute pulmonary alveolar hypoxia increases lung and plasma endothelin-1 levels in conscious rats. Life Sci. 48:1991;969-976.
22. Lazor R., Feihl F., Waeber B., et al. Endothelin-1 does not mediate the endothelin dependent hypoxic contractions of small pulmonary arteries in rats. Chest. 110:1996;189-197.
23. Wong J., Vanderford P.A., Winters J.W., et al. Endothelin-1 does not mediate acute hypoxic pulmonary vasoconstriction in the intact newborn lamb. J Cardiovasc Pharmacol. 22:1993;S262-S266.
24. Franco-Cereceda A., Holm P. Selective or nonselective endothelin antagonists in porcine hypoxic pulmonary hypertension? J Cardiovasc Pharmacol. 31:1998;S447-S452.
25. Bradley L.M., Czaja J.F., Goldstein R.E. Circulatory effects of endothelin in newborn piglets. Am J Physiol. 259:1990;H1613-H1617.
26. Nakamichi K., Ihara M., Kobayashi M., et al. Different distribution of endothelin receptor subtypes in pulmonary tissues revealed by the novel selective ligands BQ-123 and (Ala 1,3,11,15)ET-1. Biochem Biophys Res Commun. 182:1992;144-150.
27. Touvay C., Vilian B., Pons F., et al. Bronchopulmonary and vascular effect of endothelin in the guinea pig. Eur J Pharmacol. 176:1990;23-33.
28. Fike C.D., Kaplowitz M.R., Thomas C.J., Nelin L.D. Chronic hypoxia decreases nitric oxide production and endothelial nitric oxide synthase in newborn pig lungs. Am J Physiol. 274:1998;L517-L526.
29. Clozel M., Breu V., Grey G.A., et al. Pharmacological characterization of Bosentan, a new potent orally active non-peptide endothelial receptor antagonist. J Pharmacol Exp Ther. 270:1994;228-235.
30. Chen S.J., Chen Y.F., Meng Q.C., Durand J., Dicarlo V.S., Oparil S. Endothelin-receptor antagonist Bosentan prevents and reverses hypoxic pulmonary hypertension in rats. J Appl Physiol. 79:1995;2122-2131.
31. Weitzberg E., Hemsen A., Rudehill A., Modin A., Wanecek M., Lundberg J.M. Bosentan-improved cardiopulmonary vascular performance and increased plasma levels of endothelin-1 in porcine endotoxin shock. Br J Pharmacol. 118:1996;617-626.
32. Wanecek M., Rudehill A., Hemsen A., Lundberg J.M., Weitzberg E. The endothelin receptor antagonist, Bosentan, in combination with the cyclooxygenase inhibitor, diclofenac, counteracts pulmonary hypertension in porcine endotoxin shock. Crit Care Med. 25:1999;848-857.
33. Svartholm E., Bergqvist D., Hedner U., et al. Thromboxane A2-receptor blockade and prostacyclin in porcine Escherichia coli shock. Arch Surg. 124:1989;669-672.
34. Jesmok G., Gundel R. Thromboxane-blocked swine as an experimental model of severe intravascular inflammation and septic shock. Shock. 4:1995;379-383.
35. Lopez-Farre A., Riesco A., Espinosa G., et al. Effect of endothelin-1 on neutrophil adhesion to endothelial cells and perfused heart. Circulation. 88:1993;1166-1171.
36. McCarron R.M., Wang L., Stanimirovic D.B., Spatz M. Endothelin induction of adhesion molecule expression on human brain microvascular endothelial cells. Neurosci Lett. 156:1993;31-34.
37. Elferink J.G.R., Koster B.M. Endothelin-induced activation of neutrophil migration. Biochem Pharmacol. 48:1994;865-871.
38. Cunningham M.E., Huribal M., Bala R.J., McMillen M.A. Endothelin-1 and endothelin-4 stimulate monocyte production of cytokines. Crit Care Med. 25:1997;958-964.
39. Xie Y.W., Wolin M.S. Role of nitric oxide and its interaction with superoxide in the suppression of cardiac muscle mitochondrial respiration. Involvement in response to hypoxia-reoxygenation. Circulation. 94:1996;2580-2586.
40. Boulanger C., Luscher T.F. Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide. J Clin Invest. 85:1990;587-590.